You're reading everything related to:

covid cannabis

Product testing in Australia reveals inconsistencies over cannabinoid potency

Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...

Prohibition Partners LIVE returns this November with global cannabis conference

Cannabis market set to offer welcome relief during global recession

European Cannabis: Waking The Sleeping Giant

The consolidation of fully legalised and regulated cannabis industries in North America has powered hope that the same progressive systems might be implemented as quickly and successfully elsewhere. However, the...

Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia

Pharmin is a vertically integrated Uruguayan company, formed in June 2019 as a result of a transnational partnership of experienced and successful entrepreneurs. Today, the company is proud of its...

Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020

New data just released from the National Association of Statutory Health Insurance Funds (GKV) shows continued year on year growth of the German medicinal cannabis market, despite signs that growth...

Recreational cannabis projects beginning to emerge in Europe

Prohibitionist ideologies embedded in the international narcotic treaties have hampered the development of legal recreational cannabis programmes in Europe. However, we have seen the emergence of cannabis social clubs and...

Prohibition Partners interviews cannabinoid expert D'Arcy Bond from Newell Sciences

Newell Sciences is a fully integrated cannabinoid producer that delivers high quality cannabinoids to the global market. Prohibition Partners sits down with D’Arcy Bond, Director of Newell Sciences, to discuss...

US Congressional Committee Approves the Medical Cannabis Research Act

Key insights from THE IMPACT SERIES: Disrupting Food

Israeli cannabis patient numbers reach 60,000 as imports are on course to dominate domestic market

Cannabis patient numbers in Israel have reached a record high in 2020, breaking the 60,000 mark. However, compliance issues for local producers have hamstrung the domestic market with imports rising...

Medical cannabis patient numbers reach 20,000 in Brazil

Individual patient authorisations to import cannabis products into Brazil continue to surge, as shown by the most recent data provided by Brazilian health regulator ANVISA to Prohibition Partners.

Medical growers planning over 300 tonnes of European-grown cannabis

For the majority of the previous two decades, the Netherlands was responsible for the sole commercial cultivation of cannabis in Europe. Now, half a dozen European states produce cannabis for...

Clarification: Is Cannabis a Cure for COVID?

Currently, over 22 million people have been infected with COVID-19 worldwide and researchers estimate that it will take months before we have medicines that effectively treat or cure the virus...

news

intelligence

insights

on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.